ALIGNMENT HEALTHCARE INC (ALHC) Fundamental Analysis & Valuation

NASDAQ:ALHC • US01625V1044

Current stock price

16.99 USD
-0.13 (-0.76%)
At close:
17.25 USD
+0.26 (+1.53%)
Pre-Market:

This ALHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALHC Profitability Analysis

1.1 Basic Checks

  • In the past year ALHC has reported negative net income.
  • In the past year ALHC had a positive cash flow from operations.
  • ALHC had negative earnings in each of the past 5 years.
  • In multiple years ALHC reported negative operating cash flow during the last 5 years.
ALHC Yearly Net Income VS EBIT VS OCF VS FCFALHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.07%, ALHC is in line with its industry, outperforming 48.51% of the companies in the same industry.
  • ALHC has a Return On Equity of -0.40%. This is comparable to the rest of the industry: ALHC outperforms 53.47% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.29%, ALHC is in line with its industry, outperforming 44.55% of the companies in the same industry.
Industry RankSector Rank
ROA -0.07%
ROE -0.4%
ROIC 2.29%
ROA(3y)-13.82%
ROA(5y)-19.2%
ROE(3y)-74.31%
ROE(5y)-69.91%
ROIC(3y)N/A
ROIC(5y)N/A
ALHC Yearly ROA, ROE, ROICALHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • With a Operating Margin value of 0.37%, ALHC is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
  • ALHC has a worse Gross Margin (12.37%) than 68.32% of its industry peers.
  • In the last couple of years the Gross Margin of ALHC has declined.
Industry RankSector Rank
OM 0.37%
PM (TTM) N/A
GM 12.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-6.51%
ALHC Yearly Profit, Operating, Gross MarginsALHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 -10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALHC Health Analysis

2.1 Basic Checks

  • ALHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ALHC has been increased compared to 1 year ago.
  • ALHC has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALHC has been reduced compared to a year ago.
ALHC Yearly Shares OutstandingALHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALHC Yearly Total Debt VS Total AssetsALHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 5.22 indicates that ALHC is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.22, ALHC belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
  • ALHC has a debt to FCF ratio of 2.86. This is a good value and a sign of high solvency as ALHC would need 2.86 years to pay back of all of its debts.
  • The Debt to FCF ratio of ALHC (2.86) is better than 72.28% of its industry peers.
  • ALHC has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ALHC (1.80) is worse than 70.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 2.86
Altman-Z 5.22
ROIC/WACC0.27
WACC8.45%
ALHC Yearly LT Debt VS Equity VS FCFALHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • ALHC has a Current Ratio of 1.71. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
  • ALHC has a better Current ratio (1.71) than 69.31% of its industry peers.
  • A Quick Ratio of 1.71 indicates that ALHC should not have too much problems paying its short term obligations.
  • ALHC has a better Quick ratio (1.71) than 72.28% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.71
ALHC Yearly Current Assets VS Current LiabilitesALHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ALHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.51% over the past year.
  • The Revenue has grown by 46.06% in the past year. This is a very strong growth!
  • Measured over the past years, ALHC shows a very strong growth in Revenue. The Revenue has been growing by 32.71% on average per year.
EPS 1Y (TTM)98.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)46.06%
Revenue growth 3Y40.16%
Revenue growth 5Y32.71%
Sales Q2Q%44.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 248.11% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 27.43% on average over the next years. This is a very strong growth
EPS Next Y4562.5%
EPS Next 2Y536.03%
EPS Next 3Y321.18%
EPS Next 5Y248.11%
Revenue Next Year31.76%
Revenue Next 2Y28.82%
Revenue Next 3Y27.27%
Revenue Next 5Y27.43%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALHC Valuation Analysis

4.1 Price/Earnings Ratio

  • ALHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 38.07, which means the current valuation is very expensive for ALHC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHC is on the same level as its industry peers.
  • ALHC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.83.
Industry RankSector Rank
PE N/A
Fwd PE 38.07
ALHC Price Earnings VS Forward Price EarningsALHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K

4.2 Price Multiples

  • ALHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALHC is more expensive than 64.36% of the companies in the same industry.
  • ALHC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 30.68
EV/EBITDA 69.89
ALHC Per share dataALHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • ALHC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALHC's earnings are expected to grow with 321.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y536.03%
EPS Next 3Y321.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALHC Dividend Analysis

5.1 Amount

  • ALHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALHC Fundamentals: All Metrics, Ratios and Statistics

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (3/13/2026, 8:09:31 PM)

Premarket: 17.25 +0.26 (+1.53%)

16.99

-0.13 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)04-29
Inst Owners95.34%
Inst Owner Change-2.51%
Ins Owners3.49%
Ins Owner Change-13.6%
Market Cap3.47B
Revenue(TTM)3.95B
Net Income(TTM)-724.00K
Analysts85.26
Price Target25.59 (50.62%)
Short Float %8.66%
Short Ratio5.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.03%
Min EPS beat(2)67.92%
Max EPS beat(2)124.15%
EPS beat(4)4
Avg EPS beat(4)112.14%
Min EPS beat(4)61.17%
Max EPS beat(4)195.32%
EPS beat(8)7
Avg EPS beat(8)58.98%
EPS beat(12)10
Avg EPS beat(12)43.37%
EPS beat(16)13
Avg EPS beat(16)38.5%
Revenue beat(2)0
Avg Revenue beat(2)-0.86%
Min Revenue beat(2)-1%
Max Revenue beat(2)-0.73%
Revenue beat(4)2
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1%
Max Revenue beat(4)3.66%
Revenue beat(8)6
Avg Revenue beat(8)2.08%
Revenue beat(12)9
Avg Revenue beat(12)1.93%
Revenue beat(16)13
Avg Revenue beat(16)2.58%
PT rev (1m)0.7%
PT rev (3m)18.31%
EPS NQ rev (1m)-29.97%
EPS NQ rev (3m)-29.97%
EPS NY rev (1m)6.06%
EPS NY rev (3m)355.73%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)1.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 38.07
P/S 0.88
P/FCF 30.68
P/OCF 24.81
P/B 19.36
P/tB 24.33
EV/EBITDA 69.89
EPS(TTM)-0.01
EYN/A
EPS(NY)0.45
Fwd EY2.63%
FCF(TTM)0.55
FCFY3.26%
OCF(TTM)0.68
OCFY4.03%
SpS19.33
BVpS0.88
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.4%
ROCE 2.9%
ROIC 2.29%
ROICexc N/A
ROICexgc N/A
OM 0.37%
PM (TTM) N/A
GM 12.37%
FCFM 2.87%
ROA(3y)-13.82%
ROA(5y)-19.2%
ROE(3y)-74.31%
ROE(5y)-69.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.25%
GM growth 5Y-6.51%
F-Score6
Asset Turnover3.7
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 2.86
Debt/EBITDA 7.14
Cap/Depr 87.86%
Cap/Sales 0.68%
Interest Coverage 1.07
Cash Conversion 309.34%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.71
Altman-Z 5.22
F-Score6
WACC8.45%
ROIC/WACC0.27
Cap/Depr(3y)135.68%
Cap/Depr(5y)133.25%
Cap/Sales(3y)1.39%
Cap/Sales(5y)1.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y4562.5%
EPS Next 2Y536.03%
EPS Next 3Y321.18%
EPS Next 5Y248.11%
Revenue 1Y (TTM)46.06%
Revenue growth 3Y40.16%
Revenue growth 5Y32.71%
Sales Q2Q%44.43%
Revenue Next Year31.76%
Revenue Next 2Y28.82%
Revenue Next 3Y27.27%
Revenue Next 5Y27.43%
EBIT growth 1Y114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year753.4%
EBIT Next 3Y155.45%
EBIT Next 5Y98.73%
FCF growth 1Y1801.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y302.44%
OCF growth 3YN/A
OCF growth 5Y79.26%

ALIGNMENT HEALTHCARE INC / ALHC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALIGNMENT HEALTHCARE INC?

ChartMill assigns a fundamental rating of 4 / 10 to ALHC.


Can you provide the valuation status for ALIGNMENT HEALTHCARE INC?

ChartMill assigns a valuation rating of 3 / 10 to ALIGNMENT HEALTHCARE INC (ALHC). This can be considered as Overvalued.


What is the profitability of ALHC stock?

ALIGNMENT HEALTHCARE INC (ALHC) has a profitability rating of 1 / 10.


What is the financial health of ALIGNMENT HEALTHCARE INC (ALHC) stock?

The financial health rating of ALIGNMENT HEALTHCARE INC (ALHC) is 5 / 10.